NEO-PV-01 induces broad and durable immune responses in patients with metastatic cancers Oct. 30, 2018
Dual GLP-1/GIP agonist LY-3298176 superior to GLP-1 agonist dulaglutide for diabetes control Oct. 30, 2018
New phase Ib/IIa study explores use of AG-019 for treatment of early-onset type 1 diabetes Oct. 29, 2018
RSS